Ming Yu

833 total citations
54 papers, 644 citations indexed

About

Ming Yu is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging and Oncology. According to data from OpenAlex, Ming Yu has authored 54 papers receiving a total of 644 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 17 papers in Radiology, Nuclear Medicine and Imaging and 15 papers in Oncology. Recurrent topics in Ming Yu's work include Cancer, Hypoxia, and Metabolism (11 papers), Radiopharmaceutical Chemistry and Applications (6 papers) and Medical Imaging Techniques and Applications (5 papers). Ming Yu is often cited by papers focused on Cancer, Hypoxia, and Metabolism (11 papers), Radiopharmaceutical Chemistry and Applications (6 papers) and Medical Imaging Techniques and Applications (5 papers). Ming Yu collaborates with scholars based in China, United States and Russia. Ming Yu's co-authors include Tiansuo Zhao, Xiuchao Wang, He Ren, Jihui Hao, Jingcheng Liu, Ping Yan, Jihui Hao, He Ren, Yuehua Chen and Zhenguang Wang and has published in prestigious journals such as PLoS ONE, Biochemical and Biophysical Research Communications and Journal of Affective Disorders.

In The Last Decade

Ming Yu

50 papers receiving 639 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ming Yu China 15 279 193 192 142 73 54 644
Shuxian An China 14 266 1.0× 114 0.6× 149 0.8× 160 1.1× 61 0.8× 26 538
M. Lafitte France 14 401 1.4× 146 0.8× 146 0.8× 105 0.7× 65 0.9× 28 723
Eva Løbner Lund Denmark 15 408 1.5× 212 1.1× 235 1.2× 62 0.4× 91 1.2× 45 753
Annett Linge Germany 15 445 1.6× 238 1.2× 321 1.7× 122 0.9× 160 2.2× 42 893
Sarah J. Aitken United Kingdom 10 361 1.3× 302 1.6× 213 1.1× 52 0.4× 100 1.4× 14 785
Nils L. Visser Netherlands 12 281 1.0× 83 0.4× 168 0.9× 185 1.3× 66 0.9× 13 620
Rosalind A. Rosenthal United States 9 291 1.0× 129 0.7× 85 0.4× 103 0.7× 54 0.7× 10 526
Jeremy McGuire United States 10 320 1.1× 257 1.3× 188 1.0× 50 0.4× 111 1.5× 20 740
Xiao Sun China 16 398 1.4× 240 1.2× 145 0.8× 45 0.3× 79 1.1× 40 795
Kaori Imadome Japan 15 243 0.9× 113 0.6× 120 0.6× 112 0.8× 155 2.1× 25 483

Countries citing papers authored by Ming Yu

Since Specialization
Citations

This map shows the geographic impact of Ming Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ming Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ming Yu more than expected).

Fields of papers citing papers by Ming Yu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ming Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ming Yu. The network helps show where Ming Yu may publish in the future.

Co-authorship network of co-authors of Ming Yu

This figure shows the co-authorship network connecting the top 25 collaborators of Ming Yu. A scholar is included among the top collaborators of Ming Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ming Yu. Ming Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Nie, Pei, Guangjie Yang, Ning Wang, et al.. (2020). Additional value of metabolic parameters to PET/CT-based radiomics nomogram in predicting lymphovascular invasion and outcome in lung adenocarcinoma. European Journal of Nuclear Medicine and Molecular Imaging. 48(1). 217–230. 50 indexed citations
4.
Nie, Pei, Guangjie Yang, Ning Wang, et al.. (2020). Correction to: Additional value of metabolic parameters to PET/CT-based radiomics nomogram in predicting lymphovascular invasion and outcome in lung adenocarcinoma. European Journal of Nuclear Medicine and Molecular Imaging. 48(1). 325–327. 5 indexed citations
5.
Li, Qiang, et al.. (2017). Effect of radiation dose of dual-source computed tomography dual energy single-phase enhanced scan in patients with esophageal cancer: a perspective study. Zhōnghuá xiāohuà wàikē zázhì/Zhonghua xiaohua waike zazhi. 16(5). 527–532.
6.
Wang, Xiuchao, Jie Dong, Li Jia, et al.. (2017). HIF-2-dependent expression of stem cell factor promotes metastasis in hepatocellular carcinoma. Cancer Letters. 393. 113–124. 35 indexed citations
7.
Lang, Mingxiao, Xiuchao Wang, Hongwei Wang, et al.. (2016). Arsenic trioxide plus PX-478 achieves effective treatment in pancreatic ductal adenocarcinoma. Cancer Letters. 378(2). 87–96. 31 indexed citations
8.
Ren, He, Lingling Jia, Tiansuo Zhao, et al.. (2014). Hypoxia inducible factor (HIF)-1α directly activates leptin receptor (Ob-R) in pancreatic cancer cells. Cancer Letters. 354(1). 172–180. 41 indexed citations
9.
Yu, Ming, et al.. (2013). Identification and analysis of an impurity inducing clinical adverse effect in anti-adhesion carboxymethyl chitosan products. Journal of Pharmaceutical and Biomedical Analysis. 85. 21–27. 8 indexed citations
10.
Xia, Lu, Ping Yan, Rongfu Wang, et al.. (2012). Use of radioiodinated peptide Arg-Arg-Leu targeted to neovascularization as well as tumor cells in molecular tumor imaging. Chinese Journal of Cancer Research. 24(1). 52–59. 7 indexed citations
11.
Hu, Yi, Chunxia Qiao, Ming Lv, et al.. (2012). Arg9 facilitates the translocation and downstream signal inhibition of an anti-HER2 single chain antibody. BMC Research Notes. 5(1). 336–336. 3 indexed citations
12.
Ren, He, Tiansuo Zhao, Xiuchao Wang, et al.. (2010). Leptin upregulates telomerase activity and transcription of human telomerase reverse transcriptase in MCF-7 breast cancer cells. Biochemical and Biophysical Research Communications. 394(1). 59–63. 44 indexed citations
13.
Gong, Fengming, Xingchen Peng, Zhi Zeng, et al.. (2010). Proteomic analysis of cisplatin resistance in human ovarian cancer using 2-DE method. Molecular and Cellular Biochemistry. 348(1-2). 141–147. 33 indexed citations
14.
Wang, Jing, Lin Zhou, Ming Lv, et al.. (2008). Characterization of a Novel Anti-DR5 Monoclonal Antibody WD1 with the Potential to Induce Tumor Cell Apoptosis. Cellular and Molecular Immunology. 5(1). 55–60. 7 indexed citations
15.
Hao, Jihui, Ming Yu, Jia Li, et al.. (2007). Synergistic effects of proteasome inhibitor on TRAIL-induced apoptosis in malignant lymphoma cells. Clinical Oncology and Cancer Research. 34(3). 129–131. 1 indexed citations
16.
Wang, Jianing, Jiannan Feng, Ming Shi, et al.. (2007). De novo design of ErbB2 epitope targeting fusion protein stabilized by coiled coil structure. Molecular Immunology. 45(1). 106–116. 5 indexed citations
17.
Liu, Meng, et al.. (2007). Noninvasive Imaging of Human Telomerase Reverse Transcriptase (hTERT) Messenger RNA with 99mTc-Radiolabeled Antisense Probes in Malignant Tumors. Journal of Nuclear Medicine. 48(12). 2028–2036. 30 indexed citations
18.
Lü, Qian, Zhiyi Zhang, Ming Shi, et al.. (2006). Expression and distribution of HSP27 in response to G418 in different human breast cancer cell lines. Histochemistry and Cell Biology. 126(5). 593–601. 9 indexed citations
19.
Zhou, Tao, Qian Lu, Jianing Wang, et al.. (2006). Sequestering ErbB2 in endoplasmic reticulum by its autoinhibitor from translocation to cell surface: An autoinhibition mechanism of ErbB2 expression. Biochemical and Biophysical Research Communications. 342(1). 19–27. 12 indexed citations
20.
Yu, Ming, et al.. (2005). A study on the expression of BRCA1 & P53 and their correlation in epithelial ovarian cancer. Clinical Oncology and Cancer Research. 32(1). 18–20. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shuxian An Breakdown of academic impact, for papers by M. Lafitte Breakdown of academic impact, for papers by Eva Løbner Lund Breakdown of academic impact, for papers by Annett Linge Breakdown of academic impact, for papers by Sarah J. Aitken Breakdown of academic impact, for papers by Nils L. Visser Breakdown of academic impact, for papers by Rosalind A. Rosenthal Breakdown of academic impact, for papers by Jeremy McGuire Breakdown of academic impact, for papers by Xiao Sun Breakdown of academic impact, for papers by Kaori Imadome
Rankless by CCL
2026